Related Experiment Videos

[Chronic subdural hematoma following advanced cancer: report of three cases]

T Kinjo1, J Mukawa, E Takara

  • 1Department of Neurosurgery, University of Ryukyus, School of Medicine, Okinawa, Japan.

Insights

Advanced cancer patients developed chronic subdural hematoma (CSH). These cases highlight CSH as a rare complication in advanced cancer, often associated with bleeding issues and poor prognosis.

Area of Science:

  • Neurosurgery
  • Oncology
  • Hematology

Background:

  • Chronic subdural hematoma (CSH) is a serious condition that can occur in patients with advanced cancer.
  • The relationship between advanced malignancy and CSH is not well-established, necessitating further investigation.

Observation:

  • Three cases of CSH in patients with advanced cancer are presented, including metastatic adenocarcinoma and gastric cancer.
  • Patients presented with neurological deficits, including semicomatose and comatose states, requiring surgical evacuation of CSH.
  • Complications such as re-hemorrhage, disseminated intravascular coagulation (DIC), thrombocytopenia, and metastatic spread were observed.

Findings:

  • CSH can be a rare but significant complication in advanced cancer patients.
  • Hematological abnormalities like DIC and thrombocytopenia are frequently associated with CSH in this population.
  • Metastatic cancer involvement of the dura mater was confirmed in one case, suggesting a potential link between malignancy and CSH formation.

Implications:

  • These findings underscore the importance of considering CSH in the differential diagnosis of neurological symptoms in advanced cancer patients.
  • Early recognition and management of CSH, along with addressing underlying hematological issues, may be crucial for patient outcomes.
  • Further research is warranted to elucidate the mechanisms linking advanced cancer to CSH and to optimize treatment strategies.

Related Concept Videos